Research Analysts Issue Forecasts for NeuroBo Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:NRBO)

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) – Equities researchers at Zacks Small Cap issued their Q1 2024 earnings estimates for NeuroBo Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.95) per share for the quarter. The consensus estimate for NeuroBo Pharmaceuticals’ […]

Related Keywords

,News Ratings For Neurobo Pharmaceuticals Daily ,Neurobo Pharmaceuticals Stock Performance ,Nasdaq ,Neurobo Pharmaceuticals Inc ,Neurobo Pharmaceuticals Company Profile ,Neurobo Pharmaceuticals ,Free Report ,Zacks Small Cap ,Small Cap ,Neurobo Pharmaceutical ,Get Free Report ,G Protein Coupled Receptor ,Neurobo Pharmaceuticals Daily ,Nasdaq Nrbo ,Nrbo ,Medical ,Earnings Estimates ,